🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 13 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/08/1978 | 1,62 | 1,62 | 1,60 | 1,61 | -0,20% | 1,43% | 1.339.344 |
| 23/08/1978 | 1,62 | 1,62 | 1,60 | 1,62 | -0,20% | 0,82% | 4.036.896 |
| 22/08/1978 | 1,56 | 1,62 | 1,56 | 1,62 | +3,82% | 4,04% | 1.935.446 |
| 21/08/1978 | 1,58 | 1,58 | 1,56 | 1,56 | -1,05% | 1,47% | 1.494.029 |
| 18/08/1978 | 1,59 | 1,60 | 1,58 | 1,58 | -0,83% | 1,46% | 2.742.826 |
| 17/08/1978 | 1,60 | 1,61 | 1,59 | 1,59 | -0,42% | 1,45% | 1.976.947 |
| 16/08/1978 | 1,61 | 1,62 | 1,59 | 1,60 | -0,62% | 1,86% | 1.305.389 |
| 15/08/1978 | 1,61 | 1,63 | 1,60 | 1,61 | -0,20% | 1,65% | 1.256.342 |
| 14/08/1978 | 1,62 | 1,62 | 1,60 | 1,61 | -0,41% | 1,64% | 1.399.709 |
| 11/08/1978 | 1,62 | 1,63 | 1,61 | 1,62 | -0,41% | 1,23% | 1.169.568 |
| 10/08/1978 | 1,65 | 1,66 | 1,62 | 1,62 | -1,80% | 2,61% | 1.361.981 |
| 09/08/1978 | 1,65 | 1,69 | 1,64 | 1,65 | +0,00% | 2,81% | 1.558.166 |
| 08/08/1978 | 1,64 | 1,66 | 1,64 | 1,65 | +0,61% | 1,21% | 1.124.294 |
| 07/08/1978 | 1,67 | 1,68 | 1,64 | 1,64 | -1,79% | 2,18% | 1.116.749 |
| 04/08/1978 | 1,69 | 1,69 | 1,66 | 1,67 | -1,37% | 1,76% | 2.361.773 |
| 03/08/1978 | 1,68 | 1,70 | 1,68 | 1,70 | +2,81% | 1,58% | 7.168.320 |
| 02/08/1978 | 1,61 | 1,65 | 1,60 | 1,65 | +2,26% | 3,08% | 3.063.514 |
| 01/08/1978 | 1,60 | 1,62 | 1,58 | 1,61 | +0,82% | 2,49% | 2.905.056 |
| 31/07/1978 | 1,58 | 1,60 | 1,58 | 1,60 | +1,90% | 1,68% | 969.610 |
| 28/07/1978 | 1,55 | 1,57 | 1,55 | 1,57 | +1,28% | 1,28% | 1.595.894 |
| 27/07/1978 | 1,56 | 1,56 | 1,54 | 1,55 | -0,42% | 1,49% | 1.829.808 |
| 26/07/1978 | 1,54 | 1,56 | 1,53 | 1,56 | +0,86% | 2,36% | 2.165.587 |
| 25/07/1978 | 1,57 | 1,57 | 1,53 | 1,54 | -2,51% | 2,74% | 3.452.112 |
| 24/07/1978 | 1,59 | 1,59 | 1,56 | 1,58 | -0,42% | 1,67% | 1.795.853 |
| 21/07/1978 | 1,58 | 1,59 | 1,57 | 1,59 | +0,63% | 1,25% | 2.029.766 |
| 20/07/1978 | 1,61 | 1,62 | 1,58 | 1,58 | -1,85% | 2,47% | 2.248.589 |
| 19/07/1978 | 1,59 | 1,61 | 1,58 | 1,61 | +1,25% | 1,67% | 1.494.029 |
| 18/07/1978 | 1,60 | 1,61 | 1,58 | 1,59 | -0,83% | 2,06% | 1.826.035 |
| 17/07/1978 | 1,59 | 1,62 | 1,59 | 1,60 | +2,33% | 2,30% | 3.338.928 |
| 14/07/1978 | 1,53 | 1,57 | 1,53 | 1,57 | +2,38% | 2,82% | 1.584.576 |